Role of AMH in Prediction of Menopause

Publication date

2021-09-14

Authors

de Kat, Annelien C
Broekmans, FrankISNI 0000000395585824
Lambalk, Cornelis B

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Anti-Müllerian Hormone (AMH) is produced by small antral follicles and has evolved over the past three decades as an assumed potential marker of the number of follicles in the human ovaries, also known as ovarian reserve. This quantitative measure, given the gradual decline over time and its non-replenishable feature, could be the dreamed marker for predicting the final exhaustion of ovarian storage: the post-menopause. This introductory chapter summarizes current knowledge with regard to the contribution of serum AMH measurements to predict age of normal menopause and critically discuss its potential in this regard. Furthermore, its predictive role in the context of menopause in association with several frequently occurring fertility disorders such as premature menopause, polycystic ovarian syndrome and endometriosis are discussed. Overall, while ovarian reserve markers including AMH are unmistakably related to age at menopause, they are insufficiently precise to inform on an individual's journey of ovarian aging.

Keywords

AMH, menopause, ovarian aging, prediction, reproduction, Endocrinology, Diabetes and Metabolism

Citation

de Kat, A C, Broekmans, F J M & Lambalk, C B 2021, 'Role of AMH in Prediction of Menopause', Frontiers in Endocrinology, vol. 12, 733731, pp. 1-5. https://doi.org/10.3389/fendo.2021.733731